Global Perspective on COVID-19 Therapies, Cardiovascular Outcomes, and Implications for Long COVID: A State-of-the-Art Review.
J Community Hosp Intern Med Perspect
; 14(2): 58-66, 2024.
Article
em En
| MEDLINE
| ID: mdl-38966504
ABSTRACT
The COVID-19 pandemic has resulted in many therapies, of which many are repurposed and used for other diseases in the last decade such in Influenza and Ebola. We intend to provide a robust foundation for cardiovascular outcomes of the therapies to better understand the rationale for the clinical trials that were conducted during the COVID-19 pandemic, and to gain more clarity on the steps moving forward should the repurposing provide clinical benefit in pandemic situations. With this state-of-the-art review, we aim to improve the understanding of the cardiovascular involvement of the therapies prior to, during, and after the COVID-19 pandemic to provide meaningful findings to the cardiovascular specialists and clinical trials for therapies, moving on from the period of pandemic urgency.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Community Hosp Intern Med Perspect
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Paquistão